Propanolol: Spelling variant of Propranolol
Propanolol is a widely used spelling variant of the active substance Propranolol in the general population. Pharmaceutically and in the international nonproprietary name (INN), the substance is called Propranolol with two Rs. When people search for Propanolol in search engines, they typically mean Propranolol, a classical nonselective beta blocker that has been used in numerous indications since the 1960s (brand names Dociton, Obsidan, and generics).
This page serves as an informational reference. For a comprehensive pharmacological overview of mechanism of action, indications, dosage, side effects, and drug interactions, see the main page for the active substance: Propranolol. The brief summary presented here is intended for orientation and quick answers to typical questions about confusion between spelling variants.
Mechanism of Action
Propranolol nonselectively blocks beta 1 and beta 2 adrenoreceptors. Inhibition of beta 1 receptors in the heart reduces heart rate, contractility, and conduction. Inhibition of beta 2 receptors in smooth muscle can trigger bronchoconstriction and peripheral vasoconstriction, which is relevant in asthma and peripheral circulatory disorders.
In the central nervous system, Propranolol acts on tremor, migraine, test anxiety, and acute stress through its ability to cross the blood-brain barrier. These varied effects explain the broad range of indications, ranging from hypertension and cardiac arrhythmias to migraine prophylaxis and essential tremor. A detailed description of the mechanism is available on the Propranolol active substance page.
Indications
- Arterial hypertension, especially in younger patients or with specific comorbidities
- Coronary heart disease and stable angina pectoris
- Tachycardic cardiac arrhythmias such as supraventricular tachycardia
- Migraine prophylaxis as an established first-line option
- Essential tremor with significant improvement in studies
- Test anxiety and situational social phobia as on-demand medication
- Hyperthyroidism for symptomatic heart rate reduction
- Infantile hemangioma as an established therapy since 2008 for problematic hemangiomas
- Portal hypertension in liver cirrhosis for bleeding prophylaxis
A complete overview of indications including specific dosages can be found on the Propranolol main page.
Dosage and Administration
Hypertension and stable angina: 80 to 320 mg per day, often in two to three divided doses or as a sustained-release formulation once daily.
Migraine prophylaxis: Starting with 40 mg twice daily, increase to 80 to 160 mg per day, individual assessment after 8 to 12 weeks.
Essential tremor: 40 to 320 mg per day, individualized. Effect occurs rapidly.
Test anxiety: 10 to 40 mg approximately one hour before stress exposure as on-demand medication.
Infantile hemangioma: 1 to 3 mg per kg body weight per day in two to three divided doses over several months, with specialized pediatric supervision.
Renal insufficiency and hepatic insufficiency: Propranolol is metabolized predominantly by the liver. With severe hepatic insufficiency, cautious dosing is recommended. With renal insufficiency, no relevant dose adjustment is required.
Detailed dosing recommendations based on indication, age, and comorbidity are available on the Propranolol active substance page.
Side Effects
Common: Fatigue, bradycardia, sleep disturbances with vivid dreams, cold hands and feet, dizziness upon standing.
In asthma: Bronchospasm, so Propranolol is contraindicated in manifest asthma. Even in COPD, use must be critically evaluated.
In diabetes: Masking of hypoglycemia warning signs, especially with insulin therapy.
In bradycardia and AV block: Worsening possible, therefore history and ECG before therapy.
Rare: Depression, sexual dysfunction, worsening of psoriasis, allergic reactions.
A comprehensive overview of side effects and safety recommendations can be found on the Propranolol main page.
Drug Interactions
- Calcium antagonists such as verapamil and diltiazem: additive bradycardia and negative inotropy, combination must be critically evaluated.
- Antiarrhythmics such as amiodarone, flecainide: additive cardiac effects.
- Antidiabetics: masked hypoglycemia signs, patient education needed.
- NSAIDs: reduced antihypertensive effect.
- SSRIs with CYP2D6 inhibition (paroxetine, fluoxetine, bupropion): elevated Propranolol levels.
- Rifampicin: reduced levels due to CYP induction.
- Alcohol: enhanced hypotension and fall risk.
Special Precautions
Spelling variant: Propanolol with one R is a common but not official spelling. Correct according to the international nonproprietary name (INN) is Propranolol with two Rs. On prescriptions and pharmacy inquiries, the correct spelling should be used to avoid confusion.
Pregnancy and breastfeeding: Propranolol is one of the best-studied beta blockers in pregnancy, especially in the second trimester. During breastfeeding, transfer to breast milk occurs in small amounts and is generally acceptable. Detailed recommendations are on the Propranolol main page.
Discontinuation: Beta blockers must not be discontinued abruptly because a rebound effect with tachycardia, hypertensive crises, and risk escalation of coronary heart disease may occur. Gradual tapering over at least two weeks is standard.
Lifestyle: For migraine prophylaxis and hypertension, exercise, sleep hygiene, reduction of caffeine and alcohol, and stress management are part of therapy.
Driving ability: During the initial dosing phase, fatigue and dizziness are possible, individual assessment required.
When to see a doctor: Patients should contact their physician if they experience new shortness of breath, new bradycardia below 50 beats per minute, pronounced hypotension with dizziness, or new depressive symptoms.
You might also be interested in
- Propranolol, the correct INN and the main page for the substance
- Blood pressure medications, overview of antihypertensive classes
- Verapamil, calcium antagonist with similar heart rate reduction effect
- Diltiazem, another calcium antagonist
- Amiodarone, antiarrhythmic for complex arrhythmias
Frequently Asked Questions
Is the active substance called Propanolol or Propranolol?
Correct is Propranolol with two Rs, which is the international nonproprietary name (INN). Propanolol with one R is a very common spelling variant in search engines, forums, and patient communication, but is not pharmaceutically standardized. Prescriptions and product information state Propranolol.
Does Propranolol help with stage fright?
In low doses (10 to 40 mg) taken one hour before a stressful situation, Propranolol can reduce physical symptoms such as palpitations, trembling, and sweating. It does not directly reduce anxiety but interrupts the peripheral stress response. Medical consultation is advisable because contraindications in asthma or bradycardia must be considered.
Why must Propranolol not be stopped suddenly?
With chronic therapy, the body adapts to beta blockade, particularly through upregulation of receptors. Upon abrupt discontinuation, the sympathetic nervous system responds excessively, which can lead to tachycardia, hypertension, and cardiac events. Gradual tapering over two weeks or longer protects against this rebound reaction.
Can I exercise while taking Propranolol?
Yes, but maximum heart rate during exercise decreases significantly. Those who train should navigate based on subjective exertion rather than heart rate monitor values. Endurance sports are possible, but very intense exercise may feel different. Medical consultation regarding sport-specific exercise intensity is advisable.
Sources
- Gelbe Liste, Propranolol active substance profile
- BfArM, Federal Institute for Drugs and Medical Devices
- AWMF, Guidelines for hypertension, migraine, essential tremor
- European Society of Cardiology
Legal Notice and Disclaimer
The information provided on this page is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It does not replace the advice of a licensed physician or pharmacist. Medications should only be taken as prescribed by a physician or dispensed by a pharmacy. All information is based on product information and recognized scientific sources published at the time of preparation, with the current product information of the manufacturer being authoritative. Sanoliste assumes no liability for completeness, timeliness, or accuracy of the information presented. In case of medical emergency, call emergency number 112.